

Bicatero 50mg Tablet (Bicalutamide)
Manufactured By
Hetero
Pack Of
10
Salt Composition
Bicalutamide
Storage
Keep in cold place
ALL SUBSTITUTES
Overview
Bicatero 50mg Tablet is a non-steroidal antiandrogen medicine that acts as an androgen receptor inhibitor. This has an active ingredient, bicalutamide, that treats advanced or metastatic prostate cancer. This is prescribed in combination with a luteinizing hormone-releasing hormone (LHRH) analog as part of androgen-deprivation therapy. Bicalutamide 50mg tablet works by blocking male sex hormones, specifically testosterone, which can stimulate the growth of prostate cancer cells. This competitively binds to androgen receptors to prevent the androgen from activating these receptors and reducing the androgen-driven growth of prostate cancer cells.
The tablet is taken orally and is consumed with or without food. Doctors prescribe one tablet a day but ensure to take it at the same time to maintain consistency. The dosage of the bicalutamide 50mg tablet is determined according to the indication, the patient's condition, and the treatment response. Patients are advised not to change the dosage because it can lead to severe side effects.
Common side effects can include hot flashes, pain, weakness or fatigue, constipation, nausea, diarrhea, infection, swelling of the limbs, difficulty breathing, blood in the urine, and anemia. Also, they can undergo breast tenderness or enlargement during the treatment. Most of bicalutamide 50mg tablet side effects can leave when the body adapts to the medicine. However, if any side effects persist, inform your doctor immediately.
The medicine is generally not indicated for women or children. Patients must list all medicines, supplements, and herbal products that they are taking. The bicalutamide 50mg tablet must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | bicatero |
| Generic / Active Ingredient | Bicatero |
| Strength | 50 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | Hetero |
| Pack Size | 10 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Prostate Cancer |
Uses and Indications
Prostate Cancer
Side Effects of Bicatero 50mg Tablet
Side effects caused by the Bicatero 50mg Tablet (Bicalutamide) are normal, just like any other medicine. Consult the doctor if these symptoms worsen:
● Nausea
● Peripheral edema
● Breathlessness
● Enlargement of breasts
● Anemia
● Dizziness
● Weakness
● Weight gain
● Indigestion
● Hair loss
● Low appetite
● Low sex drive
● Blood glucose problem
Bicatero 50mg Tablet Dosage and How To Take It
Bicalutamide 50mg tablet (Bicatero) should be taken at the same time every day with or without food.
Swallow the tablet whole with water; do not crush or break it. Follow the doctor's guidance as recommended by the healthcare professional.
Safety Advice for Bicatero 50mg Tablet
- ● Alcohol: Patients should avoid consuming alcohol while taking the Bicalutamide 50mg tablet (Bicatero), as it may interfere with the effectiveness of the treatment and increase the risk of adverse effects.
- ● Driving: Bicatero 50mg Tablet (Bicalutamide) may cause dizziness or weakness in some patients. However, if you experience any unusual symptoms, avoid driving or operating machinery and consult your doctor.
- ● Pregnancy: Pregnant women should take this tablet with caution, as Bicatero 50mg causes side effects which harm the developing baby.
- ● Breastfeeding: Bicalutamide 50mg tablet (Bicatero) is not recommended for use in breastfeeding women, as it may pass into breast milk and potentially cause harm to the infant.
- ● Kidney: Patients with kidney impairment should use the Bicatero 50mg Tablet with caution and only under a doctor’s supervision, as the medication may affect kidney function and requires careful monitoring to ensure safety.
- ● Liver: Bicatero 50mg Tablet should affect the liver function. Hence, regular monitoring of liver health is recommended, and it should be used only under medical supervision.
FAQs About Bicatero 50mg Tablet
1. Is Bicatero 50mg Tablet (Bicalutamide) a chemotherapy medicine?
No, Bicatero is a hormonal therapy, not a chemotherapy drug. It works by blocking the effects of testosterone, which plays a role in the growth of cancer cells in the prostate gland.
2. Can I stop taking Bicalutamide 50mg tablet (Bicatero) if I feel better?
Stopping the Bicatero 50mg tablet early may affect the treatment outcome. Never stop or adjust the dose of the tablet without consulting a doctor.
3. What should I do if I miss a dose?
Take the dose as soon as you remember; however, if it is close to the time for your next dose, skip the missed dose. Do not take a double dose to make up for the missed one.
4. Can Bicatero 50mg Tablet (Bicalutamide) be taken with other medicines?
It is not clearly known whether this medicine can be safely used with other medications. Therefore, it is important to consult your doctor before combining Bicatero 50mg Tablet with any other medicine to ensure safe and effective treatment.
5. What is Bicatero tablet salt composition?
The active salt composition of the Bicatero 50mg tablet is Bicalutamide which help reduce testosterone hormone which is responsible for tumor growth.
References
● Cockshott, I. D. (2004). Bicalutamide: clinical pharmacokinetics and metabolism. Clinical pharmacokinetics, 43(13), 855-878.
● Kolvenbag, G. J., Blackledge, G. R., & Gotting‐Smith, K. (1998). Bicalutamide (Casodex®) in the treatment of prostate cancer: history of clinical development. The Prostate, 34(1), 61-72.
● Kolvenbag, G. J., & Blackledge, G. R. (1996). Worldwide activity and safety of bicalutamide: a summary review. Urology, 47(1), 70-79.
● Furr, B. J. A., & Tucker, H. (1996). The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology, 47(1), 13-25.
● Osguthorpe, D. J., & Hagler, A. T. (2011). Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer. Biochemistry, 50(19), 4105-4113.
Marketer Details
Hetero
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.







